28.02.2013 Views

The Principles of Clinical Cytogenetics - Extra Materials - Springer

The Principles of Clinical Cytogenetics - Extra Materials - Springer

The Principles of Clinical Cytogenetics - Extra Materials - Springer

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

588 Index<br />

Sézary syndrome (SS), t369, 404<br />

Sherman paradox, 496, 499, 505<br />

SHOX, 210, 225, 228, 229<br />

Shprintzen syndrome (see DiGeorge<br />

syndrome)<br />

Sideline, 51–53<br />

Sign<br />

minus, 33, 34, 53<br />

multiplication, 33, 53<br />

plus, 33, 34, 35, 53<br />

Signal<br />

connected, 57<br />

juxtaposed, 57<br />

separated, 57, 58<br />

split, 57<br />

Silver nitrate, 74<br />

Silver–Russell syndrome, 525<br />

SINES, 18<br />

Sister chromatid exchange (SCE), 165,<br />

166, f166, 175, 187, f187, 188,<br />

189, 356–357, 358f<br />

Sister chromatids, 15<br />

Sjögren syndrome, 398<br />

Slash, 38, 51<br />

Slide aging, 69<br />

Slide preparation, 69, f69, 98<br />

Slide scanning, 122, f124<br />

Small lymphocytic lymphoma, t368, 395<br />

Smith–Lemli–Opitz syndrome, 235<br />

Smith–Magenis syndrome, 175, t176,<br />

t179, 458, 550<br />

Smooth muscle tumors, 436–437<br />

SMZL, t369, 396-397<br />

SNRPN, 458, f465, 517, 518<br />

Society for Haematopathology, 365<br />

Sodium citrate, 0.8%, 68<br />

S<strong>of</strong>t tissue tumor cytogenetics, t422–423<br />

S<strong>of</strong>tware, imaging system, 121<br />

Solid tumor cytogenetics, 421–444,<br />

t422–424<br />

bone tumor aberrations, t422–423<br />

brain tumor aberrations, t424<br />

carcinoma aberrations, t424<br />

diagnostic applications, 427<br />

molecular cytogenetics, 425–426<br />

prognostic markers, 427<br />

sarcoma aberrations, t422–423<br />

Solid tumor molecular cytogenetics,<br />

425–426<br />

SOP manual, 93<br />

Specimen<br />

accessioning, 96<br />

analysis, 99<br />

collection, 63–64, 94<br />

amniotic fluid, 64<br />

bone marrow, 64<br />

peripheral blood, 63–64<br />

solid tissues, 64<br />

condition, assessment <strong>of</strong>, 96<br />

culture, 97<br />

handling, 63<br />

amniotic fluid, 64<br />

bone marrow, 64<br />

peripheral blood, 63–64<br />

solid tissues, 64<br />

labeling, 95, 96<br />

rejection, 95<br />

submission, 94<br />

Spermatid, 24, 25<br />

Spermatogenesis, 218<br />

and aneuploidy, 329–330<br />

Spermatogonia, 24<br />

Spermatozoa, 24, 25, 253<br />

S-phase, 207<br />

Spina bifida (see Neural tube defects)<br />

Splenic marginal zone lymphoma<br />

(SMZL), t369, 396–397<br />

Spontaneous pregnancy loss, 170, f170,<br />

171, 193, t340<br />

and chromosome abnormalities, 269,<br />

270, t273, t274<br />

natural rate <strong>of</strong>, 275<br />

Square brackets, 37, 48<br />

SRY, 249, 467, f468<br />

and anti-Mullerian hormone, 253<br />

and Sertoli cells, 253<br />

in 45,X, 249<br />

SS, t369, 404<br />

SS18-SSX, 429<br />

SSX1, 476

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!